Cargando…

Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1

OBJECTIVE: To assess the association between variant repeat (VR) interruptions in patients with myotonic dystrophy type 1 (DM1) and clinical symptoms and outcome measures after cognitive behavioral therapy (CBT) intervention. METHODS: Adult patients with DM1 were recruited within the OPTIMISTIC tria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wenninger, Stephan, Cumming, Sarah A., Gutschmidt, Kristina, Okkersen, Kees, Jimenez-Moreno, Aura Cecilia, Daidj, Ferroudja, Lochmüller, Hanns, Hogarth, Fiona, Knoop, Hans, Bassez, Guillaume, Monckton, Darren G., van Engelen, Baziel G.M., Schoser, Benedikt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054967/ https://www.ncbi.nlm.nih.gov/pubmed/33884298 http://dx.doi.org/10.1212/NXG.0000000000000572

Ejemplares similares

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort
por: Cumming, Sarah A., et al.
Publicado: (2019)

Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy
por: van As, Daniël, et al.
Publicado: (2021)

Structural white matter networks in myotonic dystrophy type 1
por: van Dorst, Maud, et al.
Publicado: (2018)

Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI
por: Heskamp, Linda, et al.
Publicado: (2019)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2019)

Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis
por: Gutschmidt, K., et al.
Publicado: (2020)

Human brain pathology in myotonic dystrophy type 1: A systematic review
por: Weijs, Ralf, et al.
Publicado: (2021)

Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
por: Landfeldt, Erik, et al.
Publicado: (2019)

Core Clinical Phenotypes in Myotonic Dystrophies
por: Wenninger, Stephan, et al.
Publicado: (2018)

Change over time in ability to perform activities of daily living in myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2020)

Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA)
por: DiPaolo, Giovanni, et al.
Publicado: (2017)

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
por: Wood, Libby, et al.
Publicado: (2017)

Analysis of the functional capacity outcome measures for myotonic dystrophy
por: Jimenez‐Moreno, Aura Cecilia, et al.
Publicado: (2019)

Analyzing walking speeds with ankle and wrist worn accelerometers in a cohort with myotonic dystrophy
por: Jimenez-Moreno, Aura Cecilia, et al.
Publicado: (2018)

High disease impact of myotonic dystrophy type 2 on physical and mental functioning
por: Tieleman, Alide A., et al.
Publicado: (2011)

Myotonic Dystrophy—A Progeroid Disease?
por: Meinke, Peter, et al.
Publicado: (2018)

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021)

Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
por: van der Plas, Ellen, et al.
Publicado: (2021)

Living with myotonic dystrophy; what can be learned from couples? a qualitative study
por: Cup, Edith HC, et al.
Publicado: (2011)

Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1
por: Seijger, Charlotte G. W., et al.
Publicado: (2016)

Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
por: Wood, Libby, et al.
Publicado: (2018)

Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1
por: Joosten, Isis B T, et al.
Publicado: (2020)

Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms
por: Schoser, Benedikt, et al.
Publicado: (2010)

Editorial: Beyond Borders: Myotonic Dystrophies–A European Perception
por: Schoser, Benedikt, et al.
Publicado: (2018)

Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
por: Wood, Libby, et al.
Publicado: (2019)

Consensus-based care recommendations for adults with myotonic dystrophy type 2
por: Schoser, Benedikt, et al.
Publicado: (2019)

An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1
por: Joosten, Isis B T, et al.
Publicado: (2022)

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial
por: Kurkiewicz, Adam, et al.
Publicado: (2020)

Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial
por: van Engelen, Baziel
Publicado: (2015)

Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 1
por: Miller, Jacob N., et al.
Publicado: (2020)

Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2022)

Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype
por: Joosten, Isis B.T., et al.
Publicado: (2022)

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2
por: Kamsteeg, Erik-Jan, et al.
Publicado: (2012)

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
por: Hintze, Stefan, et al.
Publicado: (2018)

Blood-Based Markers of Neuronal Injury in Adult-Onset Myotonic Dystrophy Type 1
por: van der Plas, Ellen, et al.
Publicado: (2022)

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
por: Flower, Michael, et al.
Publicado: (2019)

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy
por: González-Barriga, Anchel, et al.
Publicado: (2015)

Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations
por: Voermans, N. C., et al.
Publicado: (2019)

Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1
por: Besant, Georgia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n7eungok2mpo4bjl9u6khv9b4k